 PHASE I STUDY OF MT110 IN LUNG CANCER ADENOCARCINOMA AND SMALL CELL, GASTRIC CANCER OR ADENOCARCINOMA OF THE GASTRO-ESOPHAGEAL JUNCTION, COLORECTAL CANCER, BREAST CANCER, HORMONE-REFRACTORY PROSTATE CANCER, AND OVARIAN CANCER: 